I think you misunderstood me. I am only discussing NGIO S-1s currently not being approved now as the last one needs approved. The China deal has been approved and was approved over a week ago, so that should have been I would suspect a priority for the NGIO team to get that information in so the SEC can approve the last S-1. I would sincerely hope NGIO would not drag their feet in getting that information in so the S-1 can finally get approved and have done so already.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links